|
|
Volumn 16, Issue 2, 2002, Pages 191-
|
|
Probable serotonin syndrome variant in a patient receiving a selective serotonin reuptake inhibitor and a 5-HT3 receptor antagonist [2]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOLASETRON MESILATE;
DOXORUBICIN;
ONDANSETRON;
SEROTONIN 3 ANTAGONIST;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
ANTINEOPLASTIC AGENT;
INDOLE DERIVATIVE;
QUINOLIZINE DERIVATIVE;
SEROTONIN 3 RECEPTOR;
SEROTONIN ANTAGONIST;
SEROTONIN RECEPTOR;
ADULT;
BREAST CARCINOMA;
CANCER ADJUVANT THERAPY;
CASE REPORT;
CLINICAL FEATURE;
FEMALE;
HUMAN;
LETTER;
PREMEDICATION;
PRIORITY JOURNAL;
SEROTONIN SYNDROME;
BREAST TUMOR;
DRUG EFFECT;
MIDDLE AGED;
NOTE;
PSYCHOLOGICAL ASPECT;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
FEMALE;
HUMANS;
INDOLES;
MIDDLE AGED;
QUINOLIZINES;
RECEPTORS, SEROTONIN;
RECEPTORS, SEROTONIN, 5-HT3;
SEROTONIN ANTAGONISTS;
SEROTONIN SYNDROME;
SEROTONIN UPTAKE INHIBITORS;
SERTRALINE;
|
|
EID: 0036598899
PISSN: 02698811
EISSN: None
Source Type: Journal
DOI: 10.1177/026988110201600212 Document Type: Letter |
|
Times cited : (3)
|
|
References (3)
|
